CCND1 and cancer: More importantly, concomitant treatment with statins and the NF-κB inhibitor (CAPE) synergistically induced anti-cancer activities including the attenuation of proliferation and growth along with downregulation of LIN28B and cyclin D1, and restoration of let7-miRNA expression in human CRPC cells.